Head of Institute Dag Kvale and Deputy Heads of Institute Shuo-Wang Qiao and Torbjørn Omland look forward to lead the institute through a new four-year period.
The new Jebsen centre opened on 1 September and will have a duration of five years. The aim of the centre's research is to improve the prevention and treatment of heart disease. The Centre is led by Professor Torbjørn Omland.
In her new project, FINALphagy, Knævelsrud will study how autophagy is turned off in the body. One of the aims of her research is that it should be applicable in the development of new forms of cancer treatment.
Evandro Fei Fang will lead UiO's contribution to an extensive research project and network, financed through Horizon Europe. The goal is to develop a new medicine using artificial intelligence.
Stenmark receives the award for his groundbreaking research on processes in cell membranes and how misregulation of such processes affects the development of cancer.
The name of the new centre is the K.G. Jebsen Centre for Cardiac Biomarkers. The centre's research will contribute to increased knowledge about cardiac injury and heart failure. It will be led by Professor Torbjørn Omland and be located at the Institute of Clinical Medicine’s campus at Akershus University Hospital.
Therese Sørlie will lead the project in which she will investigate pre-invasive breast cancer stages where the milk ducts are filled with cancer cells, but these have not yet spread into surrounding breast tissue. The grant from the Norwegian Cancer Society is just under 6 million NOK.
Doctoral Research Fellow Christine Rootwelt-Norberg aims to become a leading professional in genetic cardiology. She recently received an award for her presentation at the EuroEcho conference.
Professor Torbjørn Omland and Professor Ole Andreassen will lead the projects, which will be awarded up to NOK 25 million each through Fellesløft IV.
The Centre has received a new allocation of NOK 9 million from Stiftelsen Kristian Gerhard Jebsen. The extension makes it possible to continue with important research in immunotherapy and precision medicine. The Centre is led by Professor Ludvig A. Munthe.
The funding goes to two new research projects that will contribute to increased knowledge about early stages of cancer development and new forms of cancer treatment.
TREATme is a network of researchers, from 30 European countries, led by Professor Randi Ulberg. The EU funded the network through the COST Action under Horizon 2020.
Professor Emeritus Bjarne Bogen received the King Olav Vs Prize for Cancer Research, from HM King Harald, at a ceremony in the University Aula on 18 October.
Raquel Bartolomé Casado is awarded the medal for her contribution to new knowledge about immunological memory in the gut. The findings from the doctoral dissertation may be important for the development of oral vaccines and treatment of intestinal diseases in the future.
Increasing vaccine scepticism makes it more difficult to achieve herd immunity. We therefore need vaccines that protect each individual even better. Gunnveig Grødeland is now initiating the EU project VAXPRED.
Professor John Torgils Vaage leads a study that will examine the effect of COVID-19 vaccination in immunocompromised and transplant patients. The study has received funding from the vaccine coalition CEPI.
The FRIMEDBIO-funding will go to six research projects that all reached the top in this call for proposals.
Professor Einar Røshol Heiervang thinks it has been rewarding to do health services research in the CARE project. The collaboration between the researchers and the authorities has contributed to proposals for amendments to the Norwegian Child Welfare Act.
Professor Stein Kaasa and international partners are among the shortlisted candidates for the Cancer Grand Challenges awards.
Exchanges and travels between Nepal and Norway are important parts of the COMENTH project. The pandemic has put a halt to this. Yet, through a partial reallocation of funds and digital solutions, the researchers have managed to implement some of the project’s activities.
The EU project REALMENT will make use of so-called Real World Data (RWD), genetic profiles and artificial intelligence (AI) to increase the quality of treatment for patients with mental disorders.